The Bioinformatics CRO Podcast

Episode 31 with Mark Kotter

Mark Kotter, co-founder and CEO of Bit Bio, discusses the uses of reprogrammed human cells in research and drug development.

On The Bioinformatics CRO Podcast, we sit down with scientists to discuss interesting topics across biomedical research and to explore what made them who they are today.

You can listen onSpotify, Apple Podcasts, Google Podcasts, Amazon, and Pandora.

Mark is co-founder and CEO of Bit Bio and neurosurgeon at the University of Cambridge. His team has developed a benchmark technology for the efficient and consistent production of human cells from stem cells for use in research, drug development, and cell therapy.

Transcript of Episode 31: Mark Kotter

Coming soon…